View in EDS

Impact of pre‐existing cardiometabolic diseases on metastatic cancer stage at diagnosis: a prospective multinational cohort study: a prospective multinational cohort study

Saved in:
Bibliographic Details
Title: Impact of pre‐existing cardiometabolic diseases on metastatic cancer stage at diagnosis: a prospective multinational cohort study: a prospective multinational cohort study
Authors: Jansana, Anna, Auguste, Aviane, Kvaskoff, Marina, Fournier, Agnès, Fontvieille, Emma, Peruchet-Noray, Laia, Biessy, Carine, Cordova, Reynalda, Nielsen Petersen, Kristina Elin, Tjønneland, Anne, Katzke, Verena, Kaaks, Rudolf, Ricceri, Fulvio, Panico, Salvatore, Contiero, Paolo, Sánchez, Maria-Jose, Castilla, Jesus, Crous-Bou, Marta, Heath, Alicia, Aglago, Elom Kouassivi, Weiderpass, Elisabete, Gunter, Marc James, Ferrari, Pietro, Riboli, Elio, Viallon, Vivian, Freisling, Heinz
Source: Cancer Commun (Lond)
Cancer Communications, Vol 44, Iss 5, Pp 593-597 (2024)
Jansana, A, Auguste, A, Kvaskoff, M, Fournier, A, Fontvieille, E, Peruchet-Noray, L, Biessy, C, Cordova, R, Nielsen Petersen, K E, Tjønneland, A, Katzke, V, Kaaks, R, Ricceri, F, Panico, S, Contiero, P, Sánchez, M-J, Castilla, J, Crous-Bou, M, Heath, A, Aglago, E K, Weiderpass, E, Gunter, M J, Ferrari, P, Riboli, E, Viallon, V & Freisling, H 2024, ' Impact of pre-existing cardiometabolic diseases on metastatic cancer stage at diagnosis : a prospective multinational cohort study ', Cancer communications (London, England), vol. 44, no. 5, pp. 593-597 . https://doi.org/10.1002/cac2.12526
Publisher Information: Wiley, 2024.
Publication Year: 2024
Subject Terms: Male, Adult, Metabolic Syndrome, 303007 Epidemiologie, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Neoplasms/pathology, Metabolic Syndrome/complications, Letters to the Journal, 3. Good health, SDG 3 - Good Health and Well-being, 303007 Epidemiology, Cardiovascular Diseases, SDG 3 – Gesundheit und Wohlergehen, Neoplasms, Humans, Female, Prospective Studies, Neoplasm Metastasis, RC254-282, Neoplasm Staging, Aged
Description: Owing to shared risk factors between cardiometabolic diseases (CMDs) and cancer, coupled with population aging, the lifetime risk of an individual developing cancer after a CMD is increasing. Furthermore, biological mechanisms such as insulin resistance or inflammation may not only predispose individuals with CMD to an elevated risk of certain types of cancer but also to a diagnosis of cancer at an advanced stage Owing to shared risk factors between cardiometabolic diseases (CMDs) and cancer, coupled with population aging, the lifetime risk of an individual developing cancer after a CMD is increasing. Furthermore, biological mechanisms such as insulin resistance or inflammation may not only predispose individuals with CMD to an elevated risk of certain types of cancer but also to a diagnosis of cancer at an advanced stage
Document Type: Article
Other literature type
File Description: application/pdf
Language: English
ISSN: 2523-3548
DOI: 10.1002/cac2.12526
Access URL: https://pubmed.ncbi.nlm.nih.gov/38487965
https://doaj.org/article/c4adff925f124ed3a0087ffe55ac0fae
https://curis.ku.dk/ws/files/386143196/Cancer_Communications_2024_Jansana_Impact_of_pre_existing_cardiometabolic_diseases_on_metastatic_cancer_stage_at.pdf
Rights: CC BY NC ND
URL: http://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
Accession Number: edsair.doi.dedup.....ddf7afb44e3c5f73e43986b419806e4d
Database: OpenAIRE
Description
Abstract:Owing to shared risk factors between cardiometabolic diseases (CMDs) and cancer, coupled with population aging, the lifetime risk of an individual developing cancer after a CMD is increasing. Furthermore, biological mechanisms such as insulin resistance or inflammation may not only predispose individuals with CMD to an elevated risk of certain types of cancer but also to a diagnosis of cancer at an advanced stage Owing to shared risk factors between cardiometabolic diseases (CMDs) and cancer, coupled with population aging, the lifetime risk of an individual developing cancer after a CMD is increasing. Furthermore, biological mechanisms such as insulin resistance or inflammation may not only predispose individuals with CMD to an elevated risk of certain types of cancer but also to a diagnosis of cancer at an advanced stage
ISSN:25233548
DOI:10.1002/cac2.12526